Outcome Evaluation of the CKD Sticker for Five Years in Shiga Prefecture

Isono, Tetsuichiro; Kunitsu, Yuki; Masuda, Kyoko; Hira, Daiki; Araki, Hisazumi; Araki, Shin‐ichi; Uzu, Takashi; Takato, Tsuyoshi

doi:10.5649/jjphcs.43.601

Cited by 3 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Appropriate pharmaceutical management through collaboration between hospitals and community pharmacists has been useful in outpatient cancer chemotherapy, chronic kidney disease, and residual medication reconciliation [ 22 , 23 , 24 ]. Residuals are generally caused by patients forgetting to take prescribed their medications or taking them incorrectly, and reconciliation such as reducing the number of prescription days is often performed at community pharmacies.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists

Ishihara,

Yamashita,

Seiki

et al. 2024

Pharmacy

View full text Add to dashboard Cite

Glucocorticoid-induced osteoporosis (GIOP) is a side effect of glucocorticoid (GC) treatment; however, despite established prevention guidelines in various countries, a gap persists between these guidelines and clinical practice. To address this gap, we implemented a collaborative intervention between hospitals and community pharmacists, aiming to assess its effectiveness. Pharmacists recommended to the prescribing doctor osteoporosis treatment for patients who did not undergo osteoporosis treatment with a fracture risk score of ≥3 via tracing reports (TRs), between 15 December 2021, and 21 January 2022. Data were extracted from electronic medical records, including prescriptions, concomitant medications, reasons for not pursuing osteoporosis treatment, and TR contents. Of 391 evaluated patients, 45 were eligible for TRs, with 34 (75.6%) being males. Prednisolone was the most common GCs administered, and urology was the predominant treatment department. Among the 45 patients who received TRs, prescription suggestions were accepted for 19 (42.2%). After undertaking the intervention, guideline adherence significantly increased from 87% to 92.5%. This improvement indicates that TRs effectively bridged the evidence–practice gap in GIOP prevention among GC patients, suggesting their potential utility. Expansion of this initiative is warranted to further prevent GIOP.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists

Ishihara,

Yamashita,

Seiki

et al. 2024

Pharmacy

View full text Add to dashboard Cite

show abstract

The Medical-economic Impact of Printing Laboratory Data on Prescriptions

Kunitsu

Morikochi

Hira

et al. 2019

Jpn. J. Pharm. Health Care Sci.

View full text Add to dashboard Cite

Current Status and Issues Regarding Pharmaceutical Management of Patients with Impaired Renal Function in Community Pharmacies:

Oginö

Kondo

Sato

et al. 2022

Jpn. J. Pharm. Health Care Sci.

View full text Add to dashboard Cite

Most patients suffering from chronic kidney disease (CKD) are outpatients, and renally excreted oral drugs are frequently dispensed at community pharmacies. Therefore, community pharmacists must verify the appropriateness of prescribed medications in such patients by examining their renal function pro les. This study aims to clarify the current status of pharmaceutical management of patients with impaired renal function at community pharmacies, and identify existing issues. A self-administered questionnaire survey was sent to randomly selected community pharmacies throughout the country, and 1,184 pharmacies returned completed response forms. Only about 7％ of all prescriptions lled by community pharmacists were accompanied by laboratory tests based on our calculation. Approximately half of the respondents reported prescription inquiries concerning overdosage of renally excreted drugs, which was virtually unchanged from a preceding study in 2013. Logistic regression analysis was employed to identify factors related to the prescription inquiries. Our results showed that "Experience with adverse drug events caused by inappropriate dosage for patients with CKD" (odds ratio: 9.59) and "Knowledge of the CKD sticker" (odds ratio: 2.04) were strongly associated. Nearly 80％ of the respondents recognized a lack of information about a patientʼs renal function as a barrier to inquiries. Awareness of the CKD sticker was on an average about 23％, but varied across prefectures, correlating with the prescription inquiries in each prefecture (r = 0.32). Collectively, our ndings emphasize a need to reconsider the mechanism by which medical institutions provide information to community pharmacies.

show abstract

Outcome Evaluation of the CKD Sticker for Five Years in Shiga Prefecture

Cited by 3 publications

References 6 publications

Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists

Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists

The Medical-economic Impact of Printing Laboratory Data on Prescriptions

Current Status and Issues Regarding Pharmaceutical Management of Patients with Impaired Renal Function in Community Pharmacies:

Contact Info

Product

Resources

About